(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Market Source Research, available for free download at the links above, examine Trinity Industries, Inc.
TRN, +0.39%
Progenics Pharmaceuticals Inc.
PGNX, +4.85%
National CineMedia, Inc.
NCMI, -1.14%
Sykes Enterprises, Incorporated
SYKE, -0.04%
Tennant Company
TNC, +1.83%
and CyberOptics Corporation
CYBE, -7.45%
on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

TRINITY INDUSTRIES, INC. (TRN) REPORT OVERVIEW

Trinity Industries' Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Trinity Industries reported revenue of -$195.40MM vs -$359.00MM and analysts estimated basic earnings per share $0.20 vs $3.54 (down 94.35%). For the twelve months ended December 31st, 2018 vs December 31st, 2017, Trinity Industries reported revenue of $2,509.10MM vs $2,397.40MM (up 4.66%) and analysts estimated basic earnings per share $1.09 vs $4.62 (down 76.41%). Analysts expect earnings to be released on April 24th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.30. The estimated EPS forecast for the next fiscal year is $1.63 and is expected to report on February 19th, 2020.

For the three months ended December 31st, 2018 vs December 31st, 2017, Progenics Pharmaceuticals reported revenue of $3.24MM vs $3.89MM (down 16.74%) and analysts estimated basic earnings per share -$0.18 vs -$0.04. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Progenics Pharmaceuticals reported revenue of $15.62MM vs $11.70MM (up 33.54%) and analysts estimated basic earnings per share -$0.87 vs -$0.73. Analysts expect earnings to be released on May 8th, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was -$0.19. The estimated EPS forecast for the next fiscal year is -$0.19 and is expected to report on March 12th, 2020.

For the three months ended December 31st, 2018 vs December 31st, 2017, National CineMedia reported revenue of $137.40MM vs $140.70MM (down 2.35%) and analysts estimated basic earnings per share $0.22 vs $0.61 (down 63.93%). For the twelve months ended December 31st, 2018 vs December 31st, 2017, National CineMedia reported revenue of $441.40MM vs $426.10MM (up 3.59%) and analysts estimated basic earnings per share $0.39 vs $0.89 (down 56.18%). Analysts expect earnings to be released on May 6th, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was -$0.03. The estimated EPS forecast for the next fiscal year is $0.43 and is expected to report on February 20th, 2020.

For the three months ended December 31st, 2018 vs December 31st, 2017, Sykes Enterprises reported revenue of $415.20MM vs $419.25MM (down 0.97%) and basic earnings per share $0.40 vs -$0.41. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Sykes Enterprises reported revenue of $1,625.69MM vs $1,586.01MM (up 2.50%) and analysts estimated basic earnings per share $1.16 vs $0.77 (up 50.65%). Analysts expect earnings to be released on May 6th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.43. The estimated EPS forecast for the next fiscal year is $2.41 and is expected to report on February 24th, 2020.

For the three months ended December 31st, 2018 vs December 31st, 2017, Tennant reported revenue of $285.21MM vs $279.30MM (up 2.12%) and analysts estimated basic earnings per share $0.43 vs -$0.18. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Tennant reported revenue of $1,123.51MM vs $1,003.07MM (up 12.01%) and analysts estimated basic earnings per share $1.86 vs -$0.35. Analysts expect earnings to be released on April 22nd, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.27. The estimated EPS forecast for the next fiscal year is $2.79 and is expected to report on February 20th, 2020.

For the three months ended December 31st, 2018 vs December 31st, 2017, CyberOptics reported revenue of $18.06MM vs $13.18MM (up 37.09%) and analysts estimated basic earnings per share $0.16 vs $0.07 (up 128.57%). For the twelve months ended December 31st, 2018 vs December 31st, 2017, CyberOptics reported revenue of $64.72MM vs $53.33MM (up 21.35%) and analysts estimated basic earnings per share $0.40 vs $0.19 (up 110.53%). Analysts expect earnings to be released on April 24th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$0.02.

Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst(R) (CFA(R)) designations and FINRA(R) BrokerCheck(R) certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that's ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.

REGISTERED MEMBER STATUS

Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA(R) charterholders, licensed securities attorneys, and registered FINRA(R) members holding duly issued CRD(R) numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at compliance@MarketSourceResearch.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.